Industry News:

Innovaro Pharmalicensing

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Innovaro Corporation

Industry news

Related news

Latest News

Unigene Receives Additional Capital in Debt Restructuring; Begins to Revamp Management Team

Solutia Announces Completion of $1,150 Million Senior Secured Credit Facility

Micromet Closes $80.5 Million Public Offering of Common Stock

Covidien Declares Quarterly Cash Dividend and Announces Share Repurchase Program

Lexicon Announces Pricing of Common Stock in Public Offering

Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering

NeuroSearch issues new shares in connection with the exercise of warrants

COMMENCEMENT OF EXERCISE PERIOD FOR CLASS B WARRANTS

PDL BioPharma Announces Conversion Rate Adjustments to Convertible Notes

Provectus Pharmaceuticals Closes $7.5 Million Private Placement

More news... | RSS Feed...

Most Viewed

Protox Revises Terms Of Private Placement

Novo Nordisk A/S - Share repurchase programme

PALATIN TECHNOLOGIES, INC. TO RAISE $2.6 MILLION DOLLARS IN REGISTERED DIRECT OFFERING

IBt Bebig and Core Oncology Inc. Discussions about possible Merger - Update

SpePharm announces the acquisition of Savene

Micromet Announces Proposed Public Offering of Common Stock

Chattem, Inc. Commences Tender Offer for All of Its Outstanding 2.00% Convertible Senior Notes Due 2013 and 1.625% Convertible SeniorNotes Due 2014

Lexicon Announces Proposed $95 Million Common Stock Offering

NEOVASC COMPLETES FINAL TRANCHE OF $1.537 MILLION NON-BROKERED PRIVATE PLACEMENT

Novartis announces USD 5 billion bond issue

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Innovaro Pharmalicensing current industry press releases.

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us